We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Advisory Committee Will Dig Into Alzheimer’s Drug Donanemab Next Month
Advisory Committee Will Dig Into Alzheimer’s Drug Donanemab Next Month
After enduring several setbacks, Lilly will pitch its antiamyloid contender donanemab to the Peripheral and Central Nervous System Advisory Committee in a June 10 meeting.